BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33576531)

  • 1. C2orf40 inhibits hepatocellular carcinoma through interaction with UBR5.
    Wu Y; Xiang Q; Lv X; Xiang X; Feng Z; Tian S; Tang J; Xiang T; Gong J
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2581-2591. PubMed ID: 33576531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
    Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
    DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway.
    Xie Z; Li W; Ai J; Xie J; Zhang X
    J Transl Med; 2022 Jun; 20(1):264. PubMed ID: 35676661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
    Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
    Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The zinc finger protein GATA4 induces mesenchymal-to-epithelial transition and cellular senescence through the nuclear factor-κB pathway in hepatocellular carcinoma.
    Xiang Q; Zhou D; He X; Fan J; Tang J; Qiu Z; Zhang Y; Qiu J; Xu Y; Lai G
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2196-2205. PubMed ID: 30995348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncSNHG3 promotes hepatocellular carcinoma epithelial mesenchymal transition progression through the miR-152-3p/JAK1 pathway.
    Li H; Wu Y; Wang R; Guo J; Yu Q; Zhang L; Zhao H; Yang H
    Genes Genomics; 2022 Jan; 44(1):133-144. PubMed ID: 34778942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
    Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C
    J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-876 Inhibits EMT and Liver Fibrosis via POSTN to Suppress Metastasis in Hepatocellular Carcinoma.
    Chen K; Li Z; Zhang M; Wang B; Peng T; Shen Y; Zhang J; Ye J; Liu Y; Tang D; Peng M; Ma D; Xiao Z; Zhang Y; Jin W; Li X
    Biomed Res Int; 2020; 2020():1964219. PubMed ID: 33083453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
    Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J
    BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA
    Gong X; Zhu Z
    Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
    [No Abstract]   [Full Text] [Related]  

  • 15. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway.
    Bai Z; Xia X; Lu J
    Med Sci Monit; 2020 Jan; 26():e919241. PubMed ID: 31955177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9.
    Yang C; Xu Y; Cheng F; Hu Y; Yang S; Rao J; Wang X
    Cell Death Dis; 2017 Aug; 8(8):e2999. PubMed ID: 28817119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RNA-binding protein SORBS2 suppresses hepatocellular carcinoma tumourigenesis and metastasis by stabilizing RORA mRNA.
    Han L; Huang C; Zhang S
    Liver Int; 2019 Nov; 39(11):2190-2203. PubMed ID: 31365778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.